NCT01289119View on ClinicalTrials.gov

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

506

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Alogliptin

Alogliptin tablets

DRUG

Placebo to alogliptin

Alogliptin placebo-matching tablets.

DRUG

Metformin

Stable metformin dose

DRUG

Pioglitazone

Stable pioglitazone dose

Trial Locations (21)

Unknown

Beijing

Fuzhou

Xiamen

Guangzhou

Haikou

Harbin

Jingzhou

Shiyan

Changsha

Wuxi

Nanchang

Changchun

Shenyang

Jinan

Shanghai

Xi’an

Tianjin

Kunming

Hangzhou

Hong Kong

Taipei County

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY